This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: Case Western Reserve University, Invenio Therapeutics Inc., Mirx Pharmaceuticals, LLC. Active years: 2017-2020.
Company Filing History:
2 out of 1,363 
1 out of 1 
1 out of 1 Years Active: 2017-2020
Title: Goutam Karan: Innovator in Myeloid Disorder Treatments
Introduction
Goutam Karan is a notable inventor based in Lexington, KY (US). He has made significant contributions to the field of medical research, particularly in the treatment of myeloid disorders. With a total of 5 patents to his name, Karan's work has the potential to impact the lives of many patients suffering from various conditions.
Latest Patents
One of Karan's latest patents involves securinine and norsecurinine analogue compounds for the treatment of myeloid disorders. This application relates to the use of these analogues, which, when administered to immature myeloid cells, promote their differentiation into mature cells that do not readily proliferate. These agents are useful in treating myeloid disorders, including myeloproliferative disorders, acute myeloid leukemia, and autoimmune diseases. Additionally, they may serve as myeloablative agents in conjunction with bone marrow transplants or stem cell therapy.
Another significant patent by Karan focuses on HDMX inhibitors and their use for cancer treatment. This invention introduces a novel class of acridine-like compounds that have shown efficacy in treating cancer. These compounds bind to and antagonize the activity of the p53 repressor, HDMX. By allowing p53 to induce apoptosis in cancerous cells, this approach offers a promising strategy for cancer treatment, especially when combined with Nutlin3.
Career Highlights
Throughout his career, Goutam Karan has worked with esteemed institutions such as Case Western Reserve University and Mirx Pharmaceuticals, LLC. His experience in these organizations has contributed to his expertise in the field of medical research and innovation.
Collaborations
Karan has collaborated with notable professionals in his field, including David Wald and Mukesh Agarwal. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.
Conclusion
Goutam Karan's innovative work in the treatment of myeloid disorders and cancer showcases his dedication to advancing medical science. His patents reflect a commitment to improving patient outcomes through targeted therapies.